Professional / Product Reference
High-Potency Turmeric Extract
NPN 80143038 · 60 capsules · UPC 628774090555
Provides antioxidants that help protect cells against oxidative damage caused by free radicals.
Product identity, ingredient specification, study applicability and document scope, read together.
Product identity + licensed information
Licensed product information
High-Potency Turmeric Extract · NPN 80143038
Licence holder: Morgan Natural Health Products Inc.
Recommended use or purpose
Provides antioxidants that help protect cells against oxidative damage caused by free radicals.
Medicinal ingredient per capsule
Curcuma longa (rhizome) extract — 250 mg, standardized to 95% curcuminoids.
Recommended dose
Health Canada licence: Adults 18 years and older, 1 capsule, 1–3 times daily. Route: oral.
Current package directions: 1 capsule, 1–2 times daily, or as directed by a physician. Follow the directions on your package; consult a health care practitioner if you need help interpreting them.
Cautions and warnings
- Ask a health care practitioner before use if you are pregnant or breastfeeding.
- Ask a health care practitioner before use if you are taking blood thinners.
- Ask a health care practitioner before use if you have a biliary disorder.
Non-medicinal ingredients
Hypromellose, magnesium stearate, microcrystalline cellulose.
Ingredient identity + source
Curcuma longa rhizome extract
250 mg per capsule, standardized to 95% total curcuminoids. Curcumin is one constituent of the curcuminoid family. A botanical source, an extract and an individual molecule are not interchangeable terms.
Current technical specification: document 0850.003.R01, version 01, NPN 80143038, UPC 628774090555, 60 capsules.
Complete ingredient profile →Standardization + biological context
This product is not labelled as using a branded ingredient, patented delivery system or proprietary absorption-enhancement technology.
Current public technical information establishes its standardization specification. No extract ratio, proprietary process or formulation-specific bioavailability multiplier is assigned here.
Curcumin is studied as a polyphenolic constituent in antioxidant-related experiments. Mechanistic research, measured exposure and clinical benefit are different evidence levels.
Human evidence + relevance
Selected independent publications are classified by the actual studied preparation. Ingredient Evidence and external Branded Ingredient Evidence are not Finished-product Evidence.
Shoba et al. · 1998
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Ingredient Evidence. Absorption context only. Piperine is not listed in this product; no absorption multiplier is attributed to it.
DR.MORGAN finished product studied: NO.
Methods, population, dose + limitations →DiSilvestro et al. · 2012
Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people
Branded Ingredient Evidence — external comparator. Context only. No evidence that this SKU contains Longvida®; findings cannot be assigned to it.
DR.MORGAN finished product studied: NO.
Methods, population, dose + limitations →Jäger et al. · 2014
Comparative absorption of curcumin formulations
Branded Ingredient Evidence — external comparators. Demonstrates why formulation matters. None is verified as this product’s ingredient; no absorption ratio transfers.
DR.MORGAN finished product studied: NO.
Methods, population, dose + limitations →Sahebkar et al. · 2013
Curcuminoids modulate pro-oxidant–antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals
Ingredient Evidence. Antioxidant research context; not evidence for disease treatment or this finished product.
DR.MORGAN finished product studied: NO.
Methods, population, dose + limitations →Traditional use and in-vitro/animal research are not substituted for human evidence. These papers do not expand this product’s licensed antioxidant claim.
Quality, testing + traceability
Turmeric quality documentation.
NPN 80143038 · Finished sample LOT 15021161.
Reported curcuminoid assay
Report 14250-1 records 210 mg total curcuminoids per capsule by HPLC-UV for the submitted sample. This assay result is separate from the nominal 237.5 mg calculation from the 250 mg / 95% specification.
The report describes the submitted sample and stated test. It is not a complete batch release certificate or a clinical efficacy study.
Document scope
Current technical information includes the product specification and available ingredient/quality summaries. Historical files are internal references and are not presented as current-lot release certificates.
A complete publishable finished-product COA matching LOT 15021161 is not currently available here. Batch-specific documentation can be requested through professional support.
Professional documentation
For additional product specifications or batch documentation, contact DR.MORGAN with the product name, NPN and lot number. The current public material is a technical summary; historical records are not current-lot release certificates.